Aviva Joseph

Title: Aviva Joseph: Innovator in Immunology

Introduction

Aviva Joseph is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of immunology through her innovative research and development. Her work focuses on the use of novel conjugates for vaccination, which has the potential to enhance immune responses in subjects.

Latest Patents

Aviva Joseph holds a patent for "Sphingoid polyalkylamine conjugates for vaccination." This invention concerns the use of a sphingoid-polyalkylamine conjugate as a capturing agent for biologically active molecules, such as antigens. The conjugates are utilized in the preparation of pharmaceutical compositions aimed at modulating the immune response of a subject. The patent also covers methods for modulating immune responses using these conjugates, as well as compositions and kits that incorporate them. A preferred conjugate from her research is N palmitoyl D-erythro sphingosyl 1 carbamoyl spermine. She has 1 patent to her name.

Career Highlights

Throughout her career, Aviva has worked with notable organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Bio-Lab, Inc. Her experience in these companies has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Aviva Joseph has collaborated with esteemed colleagues such as Yechezkel Barenholz and Eliezer Kedar. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Aviva Joseph is a trailblazer in the field of immunology, with her innovative work on sphingoid polyalkylamine conjugates paving the way for advancements in vaccination strategies. Her contributions are poised to make a significant impact on the future of immunotherapy.